Scottsdale, Arizona
Exosome supply and 503A pharmacy access for Scottsdale practices
ExaVeyra supplies research-use exosome material to licensed practices in Scottsdale from its base in Miami Beach, and because Arizona is a state where the 503A pharmacy partner holds a non-resident license, a prescriber here can also send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly. This page covers what a practice in Maricopa County can source, how it arrives from Miami Beach, and where the Arizona law questions are answered.
It speaks to the practice rather than to a patient. Nothing here names a condition, an outcome, or a use, and the Arizona sourcing guide, linked below, carries the delegation table and the statute reading that the city does not change.
What a Scottsdale practice can source
| Material | Availability here |
|---|---|
| Exosome material | Available. Research-use exosome formats, characterised per lot, shipped cold-chain from Miami Beach to licensed practices in every state and Puerto Rico. |
| Compounded 503A preparations | Available. Prepared to an individual prescription by our 503A pharmacy partner, which holds a non-resident pharmacy license for Arizona, and dispensed by that pharmacy to the patient named on the prescription. |
| Documentation | A lot-specific certificate of analysis is available on request for every exosome lot; compounded preparations carry the pharmacy label and beyond-use date. |
The practice landscape in Scottsdale
Scottsdale holds the densest concentration of aesthetic, concierge and longevity practices in Arizona, and the state sourcing guide lists it as such. The concentration runs along two corridors: Old Town and the Scottsdale Road spine south of Shea Boulevard, where dermatology, plastic surgery and medical aesthetics practices cluster near the HonorHealth Scottsdale Osborn and Shea campuses, and North Scottsdale around the Airpark and Kierland, where newer concierge, functional medicine and longevity practices have taken office and retail space. Paradise Valley lies to the west and adds a resort and private-practice population of its own.
Mayo Clinic in Arizona, whose Phoenix campus borders the northeast Valley, and the HonorHealth network anchor the clinical side of the market, and much of the practice base consists of physician-owned or nurse-practitioner-owned groups working under a collaborating physician within reach of those systems. The seasonal population matters for ordering: winter residents and the spring training and event calendar produce a demand curve that peaks from late autumn through April, and practices that order into that window tend to stage inventory in October rather than in December.
Two practical details recur in first conversations with Scottsdale accounts. The first is summer heat: a shipment that clears the carrier facility early in the morning and waits on a loading dock through the afternoon faces ambient temperatures the coolant was not sized for, so a receiving staff member should be named and reachable on the delivery day. The second is the number of practices operating from shared medical suites and executive-office buildings in the Airpark, where the delivery address and the suite that signs for the package are not always the same; both are recorded at account setup.
The hair and scalp literature, for Scottsdale practices
The hair and scalp series on this site sets out, component by component, what the peer-reviewed literature and the FDA say about each formulation class the literature discusses. What follows is what that means for sourcing in this market.
For a Scottsdale practice the hair and scalp series is most useful as a sourcing map: the evidence pages set out, component by component, what the literature and the FDA say about each formulation class, and the product category lists what the pharmacy partner prepares. Because Arizona is a licensed state, research-use exosome formats are supplied on the practice's verified account and the compounded preparations the pharmacy partner prepares are dispensed by that pharmacy against individual prescriptions, so the two travel separately under their own regimes.
The practical point the Arizona guide makes, and which applies with particular force in a market this dense with nurse-practitioner-led practices, is that who may prescribe a compounded preparation and who may perform a scalp procedure are questions the Arizona Medical Board and the Board of Nursing answer, and a supplier does not. The guide links both boards.
How material reaches Scottsdale
Cold-chain shipments dispatch from the Miami Beach facility under continuous temperature monitoring and reach Arizona practices in 1 to 3 business days, scheduled to avoid a weekend hold at the carrier hub.
Arizona law is a separate question, answered in the state guide
What a Arizona practice may offer, who in the practice may handle material, whether the state has a stem cell or regenerative-medicine statute and how any such statute reads against an acellular preparation, and which boards verify a license are covered in the Arizona sourcing guide rather than repeated here. Nothing about the city changes any of it.
Scottsdale sourcing questions
- How does cold-chain material reach a Scottsdale practice from Miami Beach?
- Shipments dispatch from the Miami Beach facility under validated temperature monitoring, route through the carrier air network to Phoenix Sky Harbor, and are delivered to the practice address the carrier holds on file. The Arizona sourcing guide states the transit range for the state; ExaVeyra schedules dispatch so that a shipment does not sit over a weekend at a carrier hub, and the receiving checks described on the cold-chain page apply on arrival, including the desert-summer point that a package left on a loading dock in July is the excursion most worth guarding against.
- Can a Scottsdale practice source both exosome material and compounded preparations?
- Yes. Arizona is a state where the 503A pharmacy partner holds a non-resident pharmacy license, so a prescriber in Scottsdale can send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly, and research-use exosome material ships to a Scottsdale suite on the practice's verified account. The two are handled under separate regimes and never share a shipment or a stocking calendar.
- Does a practice in Paradise Valley or the Airpark order any differently from one in Old Town?
- No. The account, the documentation and the shipping lane are the same across Maricopa County. What differs is the delivery address the carrier holds and the receiving practice named on the application, and a group with more than one location can list each address on a single account so that lots are traceable to the site that received them.
Sources
- City of Scottsdale, official site (accessed 15 September 2026)
- Arizona Medical Board (accessed 15 September 2026)
- Arizona State Board of Pharmacy (accessed 15 September 2026)
Last reviewed 17 September 2026 by Benn Bluestein-Veyra, M.Sc. Organic Chemistry. Availability is read from the state registry at the time of the request.
These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Exosome material distributed by ExaVeyra Sciences is supplied for Research Use Only, for medical, molecular biology, and biochemistry research applications, and ExaVeyra Sciences makes no statement about administration, route, or outcome. Compounded medications are a separate product class: they are not FDA-approved finished drug products, they are prepared under section 503A of the Federal Food, Drug, and Cosmetic Act against a prescription for an individual patient, and they are prescription products rather than research-use-only material. ExaVeyra does not supply controlled substances. This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. The FDA has not approved GHK-Cu or any exosome product for hair loss or any form of alopecia. Compounded medications are not FDA-approved; they are prepared by a licensed 503A compounding pharmacy for an individual patient against that patient’s prescription, and they are supplied to NPI-verified licensed practitioners only. Where this page discusses an FDA-approved active such as oral finasteride or topical minoxidil, the approved product’s labeling governs and nothing here modifies it. ExaVeyra Sciences is a supplier and takes no part in any diagnosis, treatment decision, or plan of care. ExaVeyra Sciences does not supply controlled substances. Findings described on this page are attributed to the peer-reviewed literature and to the agencies cited, and a citation establishes that a question was studied, not that any product is suitable for a given patient. The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here. Exosome material is supplied for Research Use Only. No exosome product is FDA-approved for any use, and ExaVeyra Sciences makes no statement about administration, route, or outcome.
Reference only. Not legal or medical advice.
The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here.
Read the full disclaimer
ExaVeyra Sciences publishes these guides as a reference for licensed practitioners. They summarize publicly available federal and state requirements as those requirements read on the review date shown above. The content is provided for general informational purposes only and does not constitute legal, medical, or regulatory advice, and it does not establish that any particular product or practice is compliant.
No attorney-client relationship, and no professional or clinical relationship of any kind, is created by accessing these materials. ExaVeyra Sciences is a supplier of research-use materials. It is not a law firm, it is not a regulatory consultant, and it takes no part in any diagnosis, treatment decision, or plan of care. Each practitioner is responsible for retaining their own legal counsel and for determining, with that counsel and the applicable state licensing boards, how the requirements described here apply to the services, staffing, and structure of their own practice.
Statutes, regulations, board rules, and agency positions are subject to amendment, supersession, and reinterpretation. ExaVeyra Sciences makes no representation or warranty as to the accuracy, completeness, timeliness, or applicability of this content to any particular practice. Citations and links to third-party sources are provided for convenience only and do not constitute an endorsement of their content.
The practitioner and the practice are solely responsible for compliance with all applicable licensing, scope of practice, supervision, ownership, facility, recordkeeping, and tax requirements, and for all clinical decisions, including the suitability of any material for a given patient. To the fullest extent permitted by law, ExaVeyra Sciences disclaims all liability for any action taken or not taken in reliance on this content.